Cas 1446274-07-2,2-((2-(1H-imidazol-1-yl)ethyl)thio)-5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluorophenyl)-1H-imidazole

1446274-07-2

Post Buying Request

Basic information

Product Name: 2-((2-(1H-imidazol-1-yl)ethyl)thio)-5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluorophenyl)-1H-imidazole
Synonyms: 2-((2-(1H-imidazol-1-yl)ethyl)thio)-5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluorophenyl)-1H-imidazole
CAS NO:1446274-07-2
Molecular Formula:
Molecular Weight: 475.417
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-((2-(1H-imidazol-1-yl)ethyl)thio)-5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluorophenyl)-1H-imidazole(CAS DataBase Reference)
NIST Chemistry Reference: 2-((2-(1H-imidazol-1-yl)ethyl)thio)-5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluorophenyl)-1H-imidazole(1446274-07-2)
EPA Substance Registry System: 2-((2-(1H-imidazol-1-yl)ethyl)thio)-5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluorophenyl)-1H-imidazole(1446274-07-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1446274-07-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1446274-07-2 Suppliers

Recommended suppliers

1446274-07-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1446274-07-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,6,2,7 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1446274-07:
(9*1)+(8*4)+(7*4)+(6*6)+(5*2)+(4*7)+(3*4)+(2*0)+(1*7)=162
162 % 10 = 2
So 1446274-07-2 is a valid CAS Registry Number.

1446274-07-2Upstream product

1446274-07-2Downstream Products

1446274-07-2Relevant academic research and scientific papers

NOVEL COMPOUNDS FOR TREATMENT OF DIABETES, OBESITY OR RELATED DISORDERS

-

Page/Page column 29, (2013/07/19)

The present invention relates to compounds of the general Formula I their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, their N-oxide, metabolites, polymorphs, use of these compounds in medicine and the intermediates involved in their preparation.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1446274-07-2